Trial Profile

Biological predictors of response to antidepressants

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 10 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Escitalopram (Primary) ; Desipramine
Indications Major depressive disorder
Focus Biomarker; Therapeutic Use

Most Recent Events

04 Apr 2012 Additional lead trial centre (New York State Psychiatric Institute) added as reported by ClinicalTrials.gov.
04 Apr 2012 Planned end date changed from 1 Sep 2011 to 1 May 2012 as reported by ClinicalTrials.gov.
22 Oct 2008 Planned end date is 1 Sep 2011.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com